Ascentage Pharma Group International (AAPG) Other Non-Current Liabilities (2023 - 2024)
Historic Other Non-Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $1.1 million.
- Ascentage Pharma Group International's Other Non-Current Liabilities changed N/A to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $860000.0 for FY2024, which is 6678.71% down from last year.
- As of Q2 2025, Ascentage Pharma Group International's Other Non-Current Liabilities stood at $1.1 million.
- In the past 5 years, Ascentage Pharma Group International's Other Non-Current Liabilities registered a high of $2.5 million during Q4 2023, and its lowest value of $873439.3 during Q4 2024.
- In the last 3 years, Ascentage Pharma Group International's Other Non-Current Liabilities had a median value of $1.1 million in 2025 and averaged $1.5 million.
- Data for Ascentage Pharma Group International's Other Non-Current Liabilities shows a peak YoY increase of 6563.29% (in 2024) and a maximum YoY decrease of 6563.29% (in 2024) over the last 5 years.
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Other Non-Current Liabilities stood at $2.5 million in 2023, then crashed by 65.63% to $873439.3 in 2024, then increased by 21.14% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q2 2025, $873439.3 for Q4 2024, and $2.5 million during Q4 2023.